Bartizal Ken
Chief Development Officer at Trius Therapeutics Inc
- Sold, on record
- $235k
- Dollars the filings state
- Form 4 sales
- 5
- Latest Jul 1, 2013
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Trius Therapeutics IncChief Development Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Trius Therapeutics IncPlan not statedNov 17, 2011 2011
Sold 1,687 shares at $7.85 ($13k)
Bartizal Ken, Chief Development Officer
Sold 1.5% of holdings ($876k position)109,844 shares leftFirst sale on recordFiling
- 2 Form 4 sale Trius Therapeutics IncPlan not statedMay 14, 2013 +544 days
Sold 12,000 shares at $7.85 ($94k)
Bartizal Ken, Chief Development Officer
Sold 10.8% of holdings ($871k position)98,927 shares leftFiling
- 3 Form 4 sale Trius Therapeutics IncPlan not statedMay 24, 2013 +10 days
Sold 12,000 shares at $7.93 ($95k)
Bartizal Ken, Chief Development Officer
Sold 10.8% of holdings ($880k position)98,927 shares leftFiling
- 4 Form 4 sale Trius Therapeutics IncPlan not statedJun 4, 2013 +11 days
Sold 2,000 shares at $7.90 ($16k)
Bartizal Ken, Chief Development Officer
Sold 2% of holdings ($784k position)97,300 shares left0.2x usual sizeFiling
- 5 Form 4 sale Trius Therapeutics IncPlan not statedJul 1, 2013 +27 days
Sold 2,000 shares at $8.14 ($16k)
Bartizal Ken, Chief Development Officer
Sold 2.1% of holdings ($792k position)95,300 shares left0.3x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (5)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jul 1, 2013 | Jul 1, 2013 | Trius Therapeutics Inc | Chief Development Officer | Form 4 sale | 2,000 | $16k | 2.1% | Plan not stated | SEC |
| Jun 4, 2013 | Jun 4, 2013 | Trius Therapeutics Inc | Chief Development Officer | Form 4 sale | 2,000 | $16k | 2.0% | Plan not stated | SEC |
| May 24, 2013 | May 28, 2013 | Trius Therapeutics Inc | Chief Development Officer | Form 4 sale | 12,000 | $95k | 10.8% | Plan not stated | SEC |
| May 14, 2013 | May 16, 2013 | Trius Therapeutics Inc | Chief Development Officer | Form 4 sale | 12,000 | $94k | 10.8% | Plan not stated | SEC |
| Nov 17, 2011 | Nov 18, 2011 | Trius Therapeutics Inc | Chief Development Officer | Form 4 sale | 1,687 | $13k | 1.5% | Plan not stated | SEC |